Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← Analysis & Perspectives
MillimanJune 11, 2025

Gene Therapy Access Gaps for Sickle Cell Disease Carry Big Medicaid Implications

Milliman examines barriers limiting patient access to new sickle cell disease (SCD) cell and gene therapies, including treatment center geography, hospital capacity, long lead times, and ancillary services like fertility preservation. Because SCD disproportionately affects Medicaid beneficiaries, the paper's recommendations on improving insurance coverage design are relevant for Medicaid managed care plans grappling with high-cost specialty drug coverage and network adequacy for rare disease treatment.

Pharmacy · Managed Care

Read the full analysis at Milliman →

This is outside commentary from Milliman, not part of Medicaid Monitor's independently scored news coverage.

Share this

More from Milliman

← Analysis & Perspectives

Get the daily briefing.